Sanofi SA (SNY) Stock Price Today
Aura AI Summary
Key Stats
- $109.50BMarket Cap
- -Volume
- HealthSector
- $52.3452W High
- $41.3352W Low
- -Typical Hold Time
- $129.61BEnterprise Value
- 5.33%Div Yield
- -Trading Activity
Track Sanofi SA (SNY) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Sanofi SA has traded between a low of $41.33 and a high of $52.34, highlighting its annual price range. Buy and sell Sanofi SA shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.
About Sanofi SA
Sanofi develops and markets drugs with a concentration in oncology, immunology, cardiovascular disease, diabetes, and vaccines. However, the company's decision in late 2019 to pull back from the cardio-metabolic area will likely reduce the firm's footprint in this large therapeutic area. The company offers a diverse array of drugs with its highest revenue generator, Dupixent, representing just over 10% of total sales, but profits are shared with Regeneron. About 30% of total revenue comes from the United States and 25% from Europe. Emerging markets represent the majority of the remainder of revenue.
Most Recent News
Meta's $18B legal settlement costs $1B/year, minimal impact on revenue and growth potential.
Meta has agreed to an $18 billion legal settlement, which translates to about $1 billion per year—an amount negligible compared to its substantial revenue and earnings. The settlement resolves regulatory uncertainties, allowing Meta to focus on its c...
US-Iran conflict settles into prolonged standoff with economic pressure as main US strategy.
Six months after the US and Israel launched combat operations in Iran, the conflict remains a stalemate with no clear resolution. The Trump administration has shifted from military action to economic pressure, including secondary sanctions, aiming to...
OpenAI launches ads on ChatGPT in India to boost revenue before 2027 IPO
OpenAI has introduced advertisements on ChatGPT for free users and those on its low-cost 'Go' plan in India, one of its largest markets. This move aims to increase revenue ahead of its planned 2027 public listing and support broader access through fr...
People also bought
Frequently Asked Questions
All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.